*Hox* genes are key players in the organization of the animal body plan. They encode transcription factors, the combination of which can instruct cells at different body levels as to their future morphological contributions. In addition to this ancestral function along the anterior-to-posterior (AP) axis, HOX proteins also participate in the organization of secondary axes or of a variety of organs or structures. In many animals displaying a bilateral symmetry, *Hox* genes are found clustered in the genome. This particular genomic topology has a functional relevance, as the succession of genes in *cis* within the cluster corresponds to the order of their expression domains along the various axes. This colinearity phenomenon was initially proposed by Lewis ([@r1]) in *Drosophila* and subsequently extended to vertebrates ([@r2][@r3][@r4]--[@r5]). In fact, *Drosophila* shows a breakpoint into the *Hox* cluster ([@r6]), which was thus split into 2 subclusters, a separation that occurred repetitively at different positions within drosophilids ([@r7]). Also, some species display a complete disaggregation of their ancestral cluster into a collection of single gene loci, such as in Urochordata ([@r8]).

The existence of an entire *Hox* gene cluster---that is, when all major paralogy groups are present and linked together in *cis*---was proposed to be always associated with animals whose segmental development occurs in a rostral-to-caudal time sequence. In such animals, the activation of *Hox* genes must occur following a precise timing, referred to as the *Hox* clock, which would be either regulated or coordinated by the clustered organization (see references within ref. [@r9]). The availability of genome sequences for all major groups of animals has not yet proved this conjecture wrong. However, genome analyses have revealed an unexpected property for vertebrate *Hox* clusters, which differ from their invertebrate counterparts by a higher order in their structural organization. For instance, vertebrate *Hox* clusters are barely over 100 kb in size (with the exception of axolotl; see *Discussion*), whereas cephalochordate or echinoderm clusters are around 500 kb large, similar to all characterized single invertebrate clusters ([*SI Appendix*, Fig. S1*A*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)). Therefore, the current situation is that not a single animal outside gnathostome (jawed) vertebrates has been reported to carry a complete *Hox* gene cluster of a size and compaction level close to that of vertebrates ([*SI Appendix*, Fig. S1*B*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)).

In addition to their general reduction in size, vertebrate *Hox* clusters contain little if any repeats; they never include genes unrelated to the *Hox* family; and they transcribe all their genes from the same DNA strand, with a direction of transcription opposite to the time sequence of gene activation. Another important difference between the vertebrate genomes and those of cephalochordates, echinoderms, and most invertebrates is that they contain multiple copies of their *Hox* clusters as a result of the 2 initial rounds of genome duplication ([@r10][@r11]--[@r12]). This exact correlation between the number of *Hox* gene clusters on the one hand, and their higher level of compaction and organization on the other hand, lead to the proposal that these 2 distinct aspects may have coevolved at the origin of the vertebrate lineage. A possible scenario was proposed whereby much in the same way that neofunctionalization can occur after horizontal or vertical gene duplication, global gene regulation achieved through the flanking regulatory landscapes may have been favored after duplication of the entire gene cluster ([*SI Appendix*, Fig. S1*C*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)). In this view, the duplication of genomic *Hox* loci may have allowed emergence of multiple potent enhancer sequences located outside the clusters and controlling several *Hox* genes at once. The potential negative effects of such high-order regulations and structures---for example, on the ancestral colinear mechanism at work during axial extension---could have been compensated for by having several clusters implementing this colinear process at the same time ([@r13]).

On the other hand, the evolution of de novo global enhancers may have represented an interesting adaptive value, in particular to evolve redundancy, compensatory mechanism, or quantitative regulatory controls. As a result of this accumulation of enhancers in the regulatory landscapes flanking *Hox* clusters, the genes (or subgroups thereof) would have progressively maximized their responses to these enhancers, leading to a stepwise elimination of interfering repeat sequences, shortening of intergenic distances, and placing all genes in the same transcriptional orientation. The latter point is of importance, for in such a tightly organized group of genes, the inversion of a transcription unit could either interfere with the neighboring genes' transcription or bring 2 promoters close to one another, leading to similar regulatory controls---a situation that would go against the general principle governing the evolution of this temporal mechanism in vertebrates. The presence of bound CTCF protein, a factor known to be involved in the insulation of chromatin domains ([@r14], [@r15]) between almost every gene of the cluster ([@r16]), supports the importance of this iterative genomic topology for a precise processing of gene activation.

In this study, we investigate the importance of transcriptional directionality in physiological conditions by producing and analyzing a set of targeted inversions within the *HoxD* cluster and looking at the induced effects over the neighboring genes in various developmental contexts. We report the impact of inverting both the *Hoxd11* and *Hoxd12* loci, separately, without disturbing the distribution of intervening CTCF sites, as well as the effect of a combined inversion of the 2 loci together, along with the repositioning of an inverted CTCF site. While the former 2 inversions revealed regulatory disturbances, they led to rather minor effects, whose long-term impact on the animals was difficult to evaluate. The larger *Hoxd11*--*Hoxd12* inversion, in contrast, elicited a dramatic up-regulation of the neighboring *Hoxd13* gene. By using additional engineered alleles, we show that this up-regulation is likely due to the reorganization of chromatin microdomains, rather than the leakage of transcription on the opposite DNA strand, sent toward *Hoxd13* by the inverted *Hox* genes. We show that such chromatin domains are separated by a critical CTCF site, the deletion of which also leads to a transitory up-regulation of *Hoxd13* in the developing metanephric kidneys. Finally, we use a different allele to illustrate the deleterious effect of a stable gain of expression of *Hoxd13* in developing metanephros.

Results {#s1}
=======

Inversion of the *Hoxd11* Locus. {#s2}
--------------------------------

We used CRISPR-Cas9 to produce a first inversion involving the *Hoxd11* transcription unit. The 5′ part of the *HoxD* cluster was selected due to the rather late timing of activation of these genes, which makes their study easier in terms of developmental stages, amount of material to collect, and phenotypes to observe than their more 3′-located neighbors. This inversion was designed not to interfere with neighboring transcription start or termination sites and did not include any of the CTCF binding sites ([Fig. 1*A*](#fig01){ref-type="fig"}). Therefore, any effects not generated by the mere inversion of *Hoxd11* transcription were reduced to a minimum.

![(*A*, *Upper*) Scheme of the *HoxD*^*inv(11)*^ allele. The inversion is 4.6 kb in size. (*A*, *Lower*) CTCF ChIPmentation profile from E13.5 wild-type metanephros. (*B*) WISH of *Hoxd12*, *Hoxd11*, and *Hoxd10* in E12.5 embryo. Homozygous *inv(11)* and wild-type littermates were used. (Magnification, 5×.) The different expression patterns of *Hoxd11* are all preserved in the *inv(11)* allele (blue arrows and black arrowhead). In contrast, the expression of both *Hoxd12* and *Hoxd10* is substantially reduced in the *inv(11)* mutant embryos (red and black arrows). In particular, *Hoxd12* is no longer detectable along the trunk axis, whereas the signal intensity is reduced both in the proximal and distal limb domains (red arrows). Dashed lines mark the anterior position of the hindlimb for reference.](pnas.1904602116fig01){#fig01}

A strain referred to as *HoxD*^*inv(11)*^ was produced and is mentioned as *inv(11)* mice or allele throughout this work. Animals carrying this inversion were analyzed by whole-mount in situ hybridization (WISH) at embryonic day 12.5 (E12.5). In control animals, *Hoxd11* expression was well established both along the primary body axis, where it labeled the transition between the lumbar and the sacral regions ([Fig. 1 *B*](#fig01){ref-type="fig"}, *Top Center*, arrowhead), as well as the proximal and distal parts of developing limb buds (blue arrows). At the same stage, *Hoxd12* was expressed more posteriorly, whereas *Hoxd10* transcripts were found at more anterior positions, following the rule of colinearity ([Fig. 1 *B*](#fig01){ref-type="fig"}, *Top Left* and *Top Right*, respectively), whereby the more 5′ located a gene is positioned within its *Hox* cluster, the later this gene will be activated and the more posterior its expression domain will be.

WISH using homozygous *inv(11)* mutant littermates showed a clear decrease in the amount of detected *Hoxd10* and *Hoxd12* messenger RNAs (mRNAs) visible in both the developing trunk axis and limb buds ([Fig. 1 *B*](#fig01){ref-type="fig"}, *Bottom*). Because WISH is poorly quantitative, we carried out RNA sequencing (RNA-seq) analyses by using the developing digits and metanephros, which were selected because they strongly express *Hoxd11* under normal conditions and require its function for proper development. Also, these tissues express distinct combinations of other *Hoxd* genes, due to the topologies of their regulations. In presumptive digit cells, *Hoxd11* is transcribed along with *Hoxd10*, *Hoxd12*, and *Hoxd13* as well as the *Evx2* gene positioned 8.8 kb upstream of *Hoxd13*. These genes respond to series of enhancers located in the centromeric regulatory landscape (C-DOM), which coincides with a topologically associating domain (TAD) ([*SI Appendix*, Fig. S1*C*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)) ([@r17]). In contrast, future metanephric cells express *Hoxd11* together with *Hoxd10*, *Hoxd9*, *Hoxd8*, and a moderate level of *Hoxd12* due to enhancers positioned in the opposite telomeric regulatory landscape (or T-DOM; [*SI Appendix*, Fig. S1*C*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)), whereas *Hoxd13* mRNAs are not detected. While expression of *Hoxd13* and *Hoxd12* is necessary for digit development, these genes are detrimental to the development of metanephric kidneys due to a probable dominant-negative effect over other HOX proteins, referred to as posterior prevalence ([@r18]).

In digit cells, *Hoxd13* is expressed the strongest, followed by *Hoxd12* and *Hoxd11* ([Fig. 2 *A* and *B*](#fig02){ref-type="fig"}). While transcription termination seems to occur faithfully for *Hoxd13*, the RNA-seq dataset obtained from *HoxD*^*del(8-13)/+*^ control fetuses revealed transcriptional leakages of both *Hoxd12* and *Hoxd11*. These 2 genes exhibit low levels of mRNAs extending toward their neighboring downstream *Hox* transcription units, *Hoxd11* and *Hoxd10*, respectively ([Fig. 2*B*](#fig02){ref-type="fig"}, arrows). After inversion of *Hoxd11* ([Fig. 2*C*](#fig02){ref-type="fig"}, shaded area), *Hoxd11* mRNAs, now encoded by the other DNA strand, continued at high level toward the *Hoxd12* transcription unit ([Fig. 2 *C*](#fig02){ref-type="fig"}, *Middle*, anti-*Hox* profile, arrow). This transcription leakage was likely due to the fact that the major termination signal for *Hoxd11* was not inverted along with the transcription unit. This abnormally elongated *Hoxd11* transcript extended up to the termination site of the *Hoxd12* mRNA, where it decreased abruptly, as shown by the superimposition of both DNA strands ([Fig. 2 *C*](#fig02){ref-type="fig"}, *Bottom* profile, black arrowhead). However, some *Hoxd11* transcripts continued to leak over the *Hoxd12* locus up to the 3′ extremity of *Hoxd13* ([Fig. 2 *C*](#fig02){ref-type="fig"}, *Bottom* profile, gray arrowhead). In parallel, transcription of *Hoxd12*, from the other DNA strand, was greatly reduced ([Fig. 2*A*](#fig02){ref-type="fig"}, arrow), as if the abnormal level and extension of *Hoxd11* transcription on the anti-*Hox* coding strand would interfere with the correct transcription process of *Hoxd12* from the normal---noninverted---strand ([Fig. 2 *C*](#fig02){ref-type="fig"}, *Top* and *Bottom* profiles).

![(*A*) Normalized quantification (FPKM) of *Hoxd* RNAs in E12.5 digits in control *HoxD*^*del(8-13)/+*^ (gray) and *HoxD*^*del(8-13)/inv11(11)*^ mutant (orange). *Hoxd* genes display quantitative colinearity, with *Hoxd13* expressed the strongest. In the *inv(11)* allele, *Hoxd12* RNAs are reduced (black arrow). (*B*) Strand-specific RNA signals from heterozygous control *HoxD*^*del(8-13)/+*^ developing digits. Both *Hoxd12* and *Hoxd11* transcripts leak toward their 3′ neighbor gene (black arrows). (*C*) Strand-specific RNA signals from transheterozygous *HoxD*^*del(8-13)/inv(11)*^ developing digits. Inversion of *Hoxd11* (shaded area) resulted in transcript leakage toward *Hoxd12* (arrow), which stopped downstream of *Hoxd12* (black arrowhead). Some transcripts extended toward *Hoxd13*, whose transcription remained unaffected until its 3′ end (gray arrowhead). (*D*) Normalized quantification (FPKM) of *Hoxd* RNAs in E13.5 metanephros. *Hoxd12* expression in the *inv(11)* allele also decreases (black arrow), despite its low level in control metanephros due to a posteriorly restricted domain. (*E*) Strand-specific RNA signals from control heterozygous *HoxD*^*del(8-13)/+*^ E13.5 metanephros. *Hoxd8* to *Hoxd11* are highly transcribed whereas *Hoxd13* and *Evx2* are silent. Some *Hoxd11* transcripts leak over *Hoxd10* (black arrow). (*F*) Strand-specific RNA signals from transheterozygous *HoxD*^*del(8-13)/inv(11)*^ mutant metanephros. Leakage of *Hoxd11* transcripts on the anti-*Hox* DNA strand was maintained (black arrow). A fraction of these transcripts extended up to *Hoxd13* 3′ UTR termination site (gray arrowhead) and thus covered *Hoxd12*. *Hoxd13* remained silent in this mutant allele. The inversion of *Hoxd11* does not reduce the amount of *Hoxd10* transcripts (green arrow). (*B*, *C*, *E*, and *F*) Signals were normalized by the number of million uniquely mapped reads. The mapped RNA signals are shown either in blue (*Hox* DNA strand) or in red (anti-*Hox* DNA strand). The inverted *Hoxd11* locus is represented by a shaded area. The vertical gray lines around *Hoxd11* in the control scheme (last track of *B* and *E*) indicate the breakpoints of the inverted allele.](pnas.1904602116fig02){#fig02}

In contrast to digit cells, developing metanephric cells do not express any *Hoxd13* mRNAs and only moderate levels of *Hoxd12*, with *Hoxd11*, *Hoxd10*, and *Hoxd9* being the most expressed genes ([Fig. 2*D*](#fig02){ref-type="fig"}). As in digit cells, however, the inversion of the *Hoxd11* locus led to a decrease in the level of *Hoxd12* mRNAs ([Fig. 2*D*](#fig02){ref-type="fig"}, arrow). Again, the *Hoxd11* transcripts now encoded by the *Hox* opposite DNA strand did not terminate after exon 2, as in the normal case ([Fig. 2*E*](#fig02){ref-type="fig"}, arrow), but extended up to the termination site of the *Hoxd12* transcripts ([Fig. 2*F*](#fig02){ref-type="fig"}, black arrow and arrowhead), with some weak but clear signal continuing over the *Hoxd12* transcription unit. Of note, in the inverted configuration, *Hoxd10* transcripts were scored as in the wild-type chromosome, showing that under normal conditions, the transcription of this gene is not dependent upon the leakage of transcripts coming from *Hoxd11* and extending up to *Hoxd10* ([Fig. 2*E*](#fig02){ref-type="fig"}, arrow).

Therefore, in this particular case, the inversion of a *Hox* gene locus induced the down-regulation of transcripts coming from the gene located immediately in 5′, likely as a result of a collision effect of the transcriptional machineries associated with the respective genes. It is unclear as to why the opposite effect was not scored---that is, why the transcription of the inverted *Hoxd11* gene was not affected by *Hoxd12* transcripts---in particular in digit cells where *Hoxd12* is normally expressed at higher levels than *Hoxd11* and where the former gene seems to also send some transcripts toward the latter ([Fig. 2*B*](#fig02){ref-type="fig"}, arrows). It is nevertheless clear that *Hoxd11* transcripts have the capacity to negatively interfere with *Hoxd12* transcription, whereas the opposite was not observed.

Inversion of the *Hoxd12* Locus. {#s3}
--------------------------------

We next inverted the *Hoxd12* transcription unit---the piece of DNA just adjacent to the *Hoxd11* 5′ inversion breakpoint---leaving in place the CTCF site separating these 2 loci from the *Hoxd13* gene ([*SI Appendix*, Fig. S2*A*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)). As for the inversion of *Hoxd11*, we looked at the effect of this inversion on the transcription profiles of developing metanephros and digits. RNA quantification of a subset of *Hoxd* genes in E13.5 metanephros revealed opposite variations in the amount of *Hoxd12* and *Hoxd11* mRNA, with an increase of *Hoxd12* transcription and a slight decrease in *Hoxd11* transcription ([*SI Appendix*, Fig. S2*B*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental), black arrows). The expression of other *Hoxd* genes remained unchanged. This increase was equally visible on the RNA-seq profiles obtained from *HoxD*^*del(8-13)/inv(12)*^ transheterozygote mutant metanephros ([*SI Appendix*, Fig. S2 *C* and *D*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental), compare red and blue profiles). The inversion of *Hoxd12* also resulted in a limited transcriptional leakage from the anti-*Hox* DNA strand, extending toward *Hoxd13* ([*SI Appendix*, Fig. S2*C*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental), black arrow). However, transcripts terminated at the same position as previously observed for the *inv(11)* allele ([Fig. 2 *C* and *F*](#fig02){ref-type="fig"} and [*SI Appendix*, Fig. S2*C*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental), gray arrowhead) and hence did not overlap with the *Hoxd13* gene. *Hoxd13* and *Evx2* remained transcriptionally silent.

During digit development, the amount of *Hoxd12* transcripts was reduced in *inv(12)*, in contrast to the situation described in metanephros, whereas other *Hoxd* genes did not display any substantial variation in RNA content ([*SI Appendix*, Fig. S2*E*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)). The RNA-seq profiles obtained from developing transheterozygous *HoxD*^*del(8-13)/inv(12)*^ mutant digits confirmed the minimal impact, if any, of this inversion on the transcription of *Hoxd13* ([*SI Appendix*, Fig. S2 *F* and *G*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)). The transcriptional leakage coming from the inverted *Hoxd12* locus abruptly terminated 3′ of *Hoxd13* ([*SI Appendix*, Fig. S2*F*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental), black arrow and gray arrowhead), at the same position already reported for the *inv(12)* allele in metanephros ([*SI Appendix*, Fig. S2*C*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)). Interestingly, in both cases, this transcript went through the position of the bound CTCF and terminated at the polyA site of *Hoxd13*, even when this latter gene was transcribed barely over background ([*SI Appendix*, Fig. S2 *C* and *F*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)).

Inversion of Both *Hoxd11* and *Hoxd12*. {#s4}
----------------------------------------

The independent inversions of either *Hoxd11* or *Hoxd12* did not significantly disturb the general transcriptional activity within the *HoxD* cluster. Importantly, both inverted DNA segments were contained between 2 bound CTCF sites, without perturbing either their locations or their orientations. Therefore, we examined an inversion of both *Hoxd11* and *Hoxd12* in *cis*, whereby the CTCF site located between *Hoxd12* and *Hoxd13* ([*SI Appendix*, Fig. S3](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental), black arrow) was inverted along with the 2 transcription units ([@r19]). In this *HoxD*^*inv(11-12)d13lacZ*^ allele, a *lacZ* cassette was introduced in-frame to the first exon of *Hoxd13*, which was thus functionally inactivated.

We compared the WISH signal before (*HoxD*^*d13lacZ*^) and after (*HoxD*^*inv(11-12)d13lacZ*^) inversion and noticed an anteriorization of the staining, indicating a gain of expression of *Hoxd13lacZ* in more anterior trunk territories in the inverted allele ([Fig. 3 *A*](#fig03){ref-type="fig"}, *Upper*, arrows). In the inverted mutant allele, *Hoxd13lacZ* was expressed at an anterior level now equivalent to that of *Hoxd11* ([Fig. 3 *A*](#fig03){ref-type="fig"}, *Right*, arrow and arrowhead). *HoxD*^*d13lacZ*^ fetuses did not show any X-gal staining in developing metanephros ([Fig. 3 *B*](#fig03){ref-type="fig"}, *Left*), in agreement with the absence of *Hoxd13* transcription normally observed in this organ located rostral to *Hoxd13* expression boundary. In contrast, a robust staining was scored in *HoxD*^*inv(11-12)d13lacZ*^ metanephros, in conjunction with the general anteriorization of *Hoxd13* expression ([Fig. 3 *B*](#fig03){ref-type="fig"}, *Right*).

![(*A*) WISH of *lacZ* and *Hoxd11* in control *HoxD*^*d13lacZ*^ and *HoxD*^*inv(11-12)d13lacZ*^ E12.5 homozygous mutant embryos. In the control, the rostral limits of *Hoxd11* and *d13lacZ* are well separated along the AP axis (black arrows). In the *inv(11-12)d13lacZ allele*, these patterns merged due to the anteriorized expression of *Hoxd13lacZ* (black arrowheads). (Magnification, 5×.) (*B*) X-gal staining of E13.5 metanephros from homozygote *HoxD*^*d13lacZ*^ (*Left*) and *HoxD*^*inv(11-12)d13lacZ*^ embryos (*Right*). Staining is scored in *HoxD*^*inv(11-12)d13lacZ*^ metanephros only. (Magnification, 3.5×.) (*C*) Strand-specific RNA profiles from homozygous *HoxD*^*d13lacZ*^ E13.5 metanephros. The reporter *Hoxd13lacZ* was not transcribed (black arrow), whereas *Hoxd12* showed a low RNA amount. RNAs leaking from *Hoxd11* to *Hoxd10* are shown (blue arrow). The dotted square represents the region inverted in the *HoxD*^*inv(11-12)d13lacZ*^ allele. (*D*) Strand-specific RNAs from homozygous *HoxD*^*inv*^*^(11-12)d13lacZ^* E13.5 metanephros. *Hoxd11* transcripts now leak over *Hoxd13lacZ* (red arrow) concomitantly with the ectopic transcription of *Hoxd13lacZ* (black arrow) (see corresponding X-gal staining in B).](pnas.1904602116fig03){#fig03}

RNA-seq profiles obtained from homozygous *HoxD*^*d13lacZ*^ E13.5 metanephros confirmed the quasi-absence of *Hoxd13lacZ* transcripts ([Fig. 3*C*](#fig03){ref-type="fig"}, black arrow), with the majority of mRNAs produced by the central *Hoxd11* to *Hoxd8* genes, all from the same *Hox* DNA strand, whereas *Hoxd12* showed a low level of activity. An important leakage of *Hoxd11* RNAs extending toward *Hoxd10* was detected ([Fig. 3*C*](#fig03){ref-type="fig"}, blue arrow). After inversion, several changes were observed. First, the transcription of *Hoxd12*, now at the relative genomic position of former *Hoxd11*, was increased. Second, *Hoxd11* transcription was maintained at a rather high level, despite its new relative position matching that of former *Hoxd12*, and its transcripts now leaked toward the *Hoxd13lacZ* gene, although on the opposite anti-*Hox* DNA strand ([Fig. 3*D*](#fig03){ref-type="fig"}, red arrow). Concomitantly, *Hoxd13lacZ* was significantly up-regulated in metanephros from inverted mutant fetuses, even though its relative position in the gene cluster had not changed ([Fig. 3*D*](#fig03){ref-type="fig"}, black arrow). These differences in RNA amounts were quantified by computing the fragments per kilobase per million reads (FPKM) values, confirming the gain of signal for both the *Hoxd13lacZ* and *Hoxd12* genes, located on opposite DNA strands ([*SI Appendix*, Fig. S4](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental), black arrows).

This ectopic activation of *Hoxd13* was accompanied by modifications in both the coverage in some histone marks and the micro--3-dimensional structure of the locus. In the control locus, PRC2-dependent H3K27me3 marks ([Fig. 4*A*](#fig04){ref-type="fig"}, orange profile), which label silent genes, were particularly enriched over both *Hoxd13* and *Evx2*, the 2 genes completely inactive during metanephros development ([Fig. 4*A*](#fig04){ref-type="fig"}, bracketed orange arrows). Other *Hoxd* genes were also labeled by this mark, although to a lesser extent, due to the presence of mixed cellular populations in this developing organ, including a fair proportion of *Hoxd*-negative cells. The transition between high and low levels of H3K27me3 marks coincided with the presence of both a bound CTCF site and a RAD21 peak ([Fig. 4*A*](#fig04){ref-type="fig"}, large blue arrowhead). This CTCF site labels the TAD boundary at the *HoxD* cluster ([Fig. 4*A*](#fig04){ref-type="fig"}, vertical dashed line and ref. [@r20]) and is positioned exactly where clusters of CTCF sites change their orientations ([Fig. 4*A*](#fig04){ref-type="fig"}, blue and red arrowheads). Therefore, it seemed that domains of high versus low H3K27me3 coverage were separated by the first CTCF site with an orientation (blue) opposed to all CTCF sites but one found in the center of the cluster (red). This transition in histone marks was reinforced by the analysis of H3K4me3 modifications ([Fig. 4*A*](#fig04){ref-type="fig"}, green profile), which displayed a distribution complementary to those of H3K27me3 marks, with a robust coverage over *Hoxd9* to *Hoxd11*, a weaker signal over *Hoxd12*, and only traces over *Hoxd13lacZ*.

![Chromatin marks, CTCF/RAD21, and 4C-seq profiles generated from either control homozygous *HoxD*^*d13lacZ*^ (*A*) or homozygous *HoxD*^*inv(11-12)d13lacZ*^ mutant (*B*) E13.5 metanephros. From top to bottom: scheme of the alleles; track 1, strand-specific RNA (adapted from [Fig. 3 *C* and *D*](#fig03){ref-type="fig"}); track 2, H3K27me3 (orange) and H3K4me3 (green) profiles; track 3, CTCF (black) and RAD21 (turquoise blue) profiles; and track 3, 4C-seq profiles using either a *lacZ* (*Upper*) or a *Hoxd9* (*Lower*) viewpoint (red pins). The H3K4me3 and H3K27me3 profiles reveal 2 domains within the *HoxD* cluster, with silent genes in 5′ and active genes in 3′. (*A*) In control metanephros, both *Hoxd13lacZ* and *Evx2* show high levels of H3K27me3 marks (bracketed orange arrows) and little if any H3K4me3 marks, with a boundary matching a CTCF/RAD21 peak (black arrow and vertical dashed dark line), which display an orientation facing the C-DOM (large blue arrowhead). 4C-seq profiles reveal that *Hoxd13lacZ* mostly contacted the 5′ domain, while *Hoxd9* had an opposite interaction tropism, respecting the position of the CTCF site (vertical dashed line). (*B*) Comparable tracks from homozygous *HoxD*^*inv(11-12)d13lacZ*^ E13.5 mutant metanephros. The inversion leads to a gain of *Hoxd13lacZ* expression along with a diminution of H3K27me3 over *Hoxd13* (bracketed orange arrows) and a gain of H3K4me3, thus repositioning the boundary between *Evx2* and *Hoxd13* (vertical dashed line). This position coincided with a pair of CTCF sites (circled), which then labeled the new centromeric side of the boundary, while the initial CTCF site (large blue arrowhead in *A*) was inverted and displaced (large red arrowhead). The latter site still binds CTCF and RAD21 (black arrow). The 4C-seq profiles after inversion were in agreement with the position of this new boundary. The *lacZ* bait had more interaction on the telomeric side than on the centromeric side, and the *Hoxd9* bait now extended its contacts up to include *Hoxd13lacZ* to stop at the new boundary. The inverted CTCF site induced a slight and local boundary effect (open arrowheads). The inverted DNA segment is shown with a shaded area. Green box indicates *lacZ* sequences.](pnas.1904602116fig04){#fig04}

In the inverted allele, the H3K27me3 and H3K4me3 profiles remained complementary ([Fig. 4*B*](#fig04){ref-type="fig"}, track 2, orange and green, respectively). However, the boundary was clearly displaced toward the centromeric end of the gene cluster. The amount of H3K27me3 over *Hoxd13lacZ* was severely reduced compared with the coverage over *Evx2* ([Fig. 4*B*](#fig04){ref-type="fig"}, bracketed orange arrows), while at the same time, H3K4me3 marks robustly increased over the *Hoxd13lacZ* gene. The boundary between these 2 complementary epigenetic profiles was now positioned between *Hoxd13lacZ* and *Evx2* ([Fig. 4*B*](#fig04){ref-type="fig"}, dashed line) and precisely matched the presence of a pair of CTCF sites orientated in the direction of the centromeric TAD (circled in [Fig. 4*B*](#fig04){ref-type="fig"}). The CTCF site that labeled this transition in the control allele ([Fig. 4*A*](#fig04){ref-type="fig"}, large blue arrowhead) no longer marked the transition in the inverted allele ([Fig. 4*B*](#fig04){ref-type="fig"}, large red arrowhead), even though this site was still occupied by CTCF and matched a peak of RAD21 in the mutant allele ([Fig. 4*B*](#fig04){ref-type="fig"}, arrow in track 3).

This shift in the position of the boundary between active and inactive domains of the *HoxD* cluster in the inverted allele was challenged by a circularized chromosome conformation capture sequencing (4C-seq) approach, whereby the contacts established by the *Hoxd13lacZ* gene ([Fig. 4 *A* and *B*](#fig04){ref-type="fig"}, track 4) were assessed before and after the inversion. In the control allele, contacts were enriched toward the centromeric side (i.e., in agreement with the position of the boundary) ([Fig. 4*A*](#fig04){ref-type="fig"}, track 4). In the inverted allele however, the bulk of contacts was now detected toward the telomeric side (i.e., following the change in the position of the boundary) ([Fig. 4*B*](#fig04){ref-type="fig"}, track 4). Therefore, the inversion importantly modified the tropism in contacts of the *Hoxd13lacZ* gene: from contacts mainly established with a repressive chromatin structure before the inversion to a clear enrichment of contacts with a transcriptionally permissive chromatin domain after the inversion. In the latter case, interestingly, the gain of contact appeared somehow restricted to the DNA interval between the new boundary ([Fig. 4*B*](#fig04){ref-type="fig"}, dashed line) and the position of the inverted CTCF site ([Fig. 4*B*](#fig04){ref-type="fig"}, large red arrowhead), as if a boundary effect was also observed at this position ([Fig. 4*B*](#fig04){ref-type="fig"}, open arrowheads).

This effect was confirmed by using a viewpoint corresponding to *Hoxd9*, on the same material. In the control *HoxD*^*d13lacZ*^ allele, *Hoxd9* established contacts with all genes up to the CTCF-labeled boundary, where interactions abruptly stopped ([Fig. 4 *A*](#fig04){ref-type="fig"}, track 4, *Lower*). In the mutant *HoxD*^*inv(11-12)d13lacZ*^ allele, however, contacts extended up to the new boundary ([Fig. 4 *B*](#fig04){ref-type="fig"}, track 4, *Lower*) corresponding to the CTCF/RAD21 doublet located between *Hoxd13lacZ* and *Evx2* (circled in [Fig. 4*B*](#fig04){ref-type="fig"}). The new boundary effect triggered by the inverted CTCF site and observed with the *Hoxd13lacZ* viewpoint ([Fig. 4*B*](#fig04){ref-type="fig"}, open arrowheads) was nevertheless also detected when using *Hoxd9* as bait. Therefore, after inversion, while *Hoxd9* interacted with *Hoxd13lacZ*, these contacts appeared to result from the interactions between 2 microsubdomains rather than from a single domain ([Fig. 4 *B*](#fig04){ref-type="fig"}, track 4, *Lower*).

Change in Chromatin Topology or Promoter Cleaning? {#s5}
--------------------------------------------------

These results suggested that local changes in chromatin topology, due to the modified position and orientation of a CTCF site, were responsible for the up-regulation of the *Hoxd13lacZ* gene in developing metanephros. Alternatively, the transcript emanating from inverted *Hoxd11* and overlapping with the *Hoxd13lacZ* gene on the opposite anti-*Hox* DNA strand could elicit a transcriptional response from the latter unit. Such "promoter cleaning" would allow subsequent control by the appropriate upstream factors, which would normally not access this promoter due to the coverage by H3K27me3 marks. To try to discriminate between these 2 explanations, we further deleted the *Hoxd11* transcription units from the inverted allele such as to abrogate the RNA leakage over *Hoxd13lacZ*. In this *HoxD*^*inv(11-12)del(11)d13lacZ*^ allele, only *Hoxd12* was left inverted and positioned at the same distance from *Hoxd13lacZ* as inverted *Hoxd11* in the *HoxD*^*inv(11-12)d13lacZ*^ allele. This secondary mutation did not affect the distribution of CTCF sites in any way ([*SI Appendix*, Fig. S5*A*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)).

WISH using a *lacZ* probe revealed that the deletion of *Hoxd11* from the *inv(11-12)d13lacZ* allele failed to suppress the anteriorization of *Hoxd13lacZ* along the AP axis of *HoxD*^*inv(11-12)d13lacZ*^ fetuses ([*SI Appendix*, Fig. S5*B*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental), black arrow). This indicated that the anteriorization was likely not due to *Hoxd11* transcripts running through the *Hoxd13lacZ* promoter, thus permitting a *lacZ* pattern similar to that of inverted *Hoxd11* ([*SI Appendix*, Fig. S5 *B*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental), *Middle* and *Right*). Also, *HoxD*^*inv(11-12)del(11)d13lacZ*^ mutant fetuses transcribed *lacZ* in their developing cecum ([*SI Appendix*, Fig. S5*B*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental), blue arrow) in a manner similar to their aged-matched *HoxD*^*inv(11-12)d13lacZ*^ counterparts (see also refs. [@r19] and [@r21]), suggesting again that this ectopic expression was not caused by a *Hoxd11* transcript leakage. Likewise, X-gal staining was scored in E13.5 *HoxD*^*inv(11-12)del(11)d13lacZ*^ metanephros as similar to or even stronger than the *HoxD*^*inv(11-12)d13lacZ*^ situation ([*SI Appendix*, Fig. S5*C*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)).

Strand-specific RNA-seq carried out using E13.5 homozygous *HoxD*^*inv(11-12)del(11)d13lacZ*^ metanephros revealed the expected transcriptional activity of *Hoxd12* on the opposite strand, as well as the strong gain of expression of the *Hoxd13lacZ* reporter gene ([*SI Appendix*, Fig. S5*D*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)). A faint *Hoxd12* transcript was detected extending up to the *Hoxd13* promoter, yet this RNA was in much lower amount than the leaking *Hoxd11* RNA observed in the *HoxD*^*inv(11-12)d13lacZ*^ allele ([*SI Appendix*, Fig. S5*D*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental); compare with [Fig. 3*D*](#fig03){ref-type="fig"}, red arrow). We compared this decrease in amount of leaking RNAs observed between the *HoxD*^*inv(11-12)del(11)d13lacZ*^ and the *HoxD*^*inv(11-12)d13lacZ*^ alleles, with a quantification of the genes' transcripts obtained by computing the FPKM described above. The steady-state levels of the various mRNA were globally comparable between the 2 alleles, yet with a clear increase in *Hoxd13lacZ* mRNAs in the *HoxD*^*inv(11-12)del(11)d13lacZ*^ allele (which expectedly also lacked any *Hoxd11* transcripts; [*SI Appendix*, Fig. S5*E*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)). This latter observation suggested a negative correlation between the amount of *Hoxd13lacZ* mRNA produced and the importance of transcript leaking on the opposite DNA strand.

Mutation of the CTCF Site. {#s6}
--------------------------

These results favored a change in local topology over a mere transcriptional leakage as a cause for the up-regulation of the *Hoxd13lacZ* reporter gene. Since the CTCF site present in the inverted DNA seemed to play a particular function in the spatial organization of these chromatin domains, we mutated this site in a wild-type background. This *HoxD*^*del(CTCF:d12d13)*^ allele was generated by CRISPR-Cas9--induced mutagenesis using a guide RNA targeting the core of the CTCF binding motif ([*SI Appendix*, Fig. S6*A*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental), pink sequence) positioned between *Hoxd12* and *Hoxd13.* The selected deletion was 21 bp in size, including 13 bp of the core CTCF motif. CTCF ChIPmentation, a modification of ChIP-seq using the transposase Tn5 to integrate sequencing adapters, performed in transheterozygote *HoxD*^*del**(CTCF:d12d13)/del(8-13)*^ E13.5 forebrain confirmed the absence of CTCF binding ([*SI Appendix*, Fig. S7*A*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental), black arrow).

Dissected metanephros of E13.5 *HoxD*^*del**(CTCF:d12d13)/del(8-13)*^ and control *HoxD*^*+/del(8-13)*^ fetuses were analyzed for their content in *Hoxd* mRNAs through normalized quantification (FPKM) computed from the RNA-seq datasets. In the absence of the CTCF site, a conspicuous gain of expression was scored for both *Hoxd12* and *Hoxd13*---that is, those 2 *Hoxd* genes normally located on the other side of the mutated CTCF site---as if the boundary effect had entirely disappeared ([*SI Appendix*, Fig. S6*B*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)). This effect was further controlled by in situ hybridization using *Hoxd13* as a probe in E13.5 embryos, which revealed a clear gain of expression of *Hoxd13* in the developing metanephros of homozygous *HoxD*^*del(CTCF:d12d13)*^ mutant embryos ([*SI Appendix*, Fig. S7*B*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)).

This gain-of-function effect observed after the mutation of a single CTCF site was rapidly compensated for, however, and ectopic *Hoxd13* was already much reduced at E18.5 and no longer scored in adult metanephros of mutant specimens, whereas *Hoxd8* and *Hoxd9* transcripts were still scored at high levels in both control and mutant adult metanephros ([*SI Appendix*, Fig. S8](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)). This result indicated that while the CTCF mutation had fragilized the boundary, the remaining CTCF sites as well as the transcription of other *Hoxd* genes might still exert a strong insulation effect, preventing HOXD13 protein to leak into the developing metanephros. Therefore, to address the potential effect of gained HOXD13 in an inversion similar to *HoxD*^*inv(11-12)d13lacZ*^, we used another allele where the gain of *Hoxd13* in metanephros was slightly more robust and stable over time such that it was still scored in adult metanephros.

Detrimental Effect of HOXD13 on Metanephric Kidney Development. {#s7}
---------------------------------------------------------------

To address this point, we used the *HoxD*^*inv(Nsi-Itga6)*^ allele, where an inversion was engineered directly upstream of *Hoxd13* up to the *Itga6* gene, 3 Mb away ([@r22]) ([Fig. 5 *A*](#fig05){ref-type="fig"}, *Top*). As a consequence, *Hoxd13* loses some of its strong contact points in the centromeric neighborhood and reallocates contacts toward its telomeric side ([@r17]), where metanephros enhancers are located ([@r23]). Using RNA-seq, we looked at whether this partial change in interaction tropism may elicit a gain of function during metanephros development, and a substantial gain was observed for *Hoxd13* transcripts, while at the same time, the levels of *Hoxd9*, *Hoxd10*, and *Hoxd11* transcripts seemed to decrease, likely due to competition between promoters ([*SI Appendix*, Fig. S9](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)).

![(*A*) Gain of *Hoxd13* expression in the metanephros of *HoxD*^*inv(Nsi-Itga6)*^ mutant specimens. The *HoxD*^*inv(Nsi-Itga6)*^ allele, also referred to as *inv(Nsi-Itga6)*, contains a large 3-Mb inversion centromeric from the *HoxD* cluster ([@r22]), with a breakpoint positioned between *Evx2* and *Hoxd13* (dashed blue line). In E13.5 metanephros, a noticeable gain of expression of both *Hoxd12 and Hoxd13* genes is scored (black arrows). The mutant heterozygote *inv(Nsi-Itag6)* and wild-type control RNA profiles are shown in mirror orientations. (*B*) Normalized quantification of the daily water intake in adult animals of different genotypes: wild type (*Top*), *HoxD*^*inv(Nsi-Itga6)/+*^ (*Middle*), and *HoxD*^*inv(Nsi-Itga6)del(13HD)/+*^ (*Bottom*). *HoxD*^*inv(Nsi-Itga6)*^ heterozygotes show a 2-fold increased consumption of water (blue arrow) compared with wild-type animals. The deletion of the *Hoxd13* homeodomain in this latter allele (*HoxD*^*inv(Nsi-Itga6)del(13HD)*^; [*SI Appendix*, Fig. S10](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)) rescues this phenotype (black arrow). (*C*) Representative sections of metanephros dissected from adult animals of different genotypes: wild type (*Left*), *HoxD*^*inv(Nsi-Itga6)*^ heterozygote (*Center*), and double-mutant *HoxD*^*inv(Nsi-Itga6)del(13HD)*^ heterozygote (*Right*). (Magnification, 12×.) Alterations are detected only in *HoxD*^*inv(Nsi-Itga6)*^ mutant specimens.](pnas.1904602116fig05){#fig05}

Mice carrying one copy of this allele were found to suffer from polydipsia; that is, they were consuming more than twice the amount of water than their control littermates ([Fig. 5*B*](#fig05){ref-type="fig"}, blue arrow). A histological analysis of heterozygous mutant metanephros revealed serious malformations, in particular at the level of the medulla, suggesting that the polydipsia was indeed due to problems in metanephric kidney development ([Fig. 5 *C*](#fig05){ref-type="fig"}, *Center*). The (*Nsi-Itga6*) inversion that caused this phenotype is large and has a breakpoint in a gene-rich region around the *Itga6* locus and, hence, the contribution of the gained HOXD13 protein in this kidney alteration remained to be clearly established.

Accordingly, we used a CRISPR-Cas9 approach to inactivate the function of the HOXD13 protein on top of the inversion. We induced a small deletion into the homeobox region of HOXD13 (the *HoxD*^*inv(Nsi-Itga6)del(13HD)*^ allele; [*SI Appendix*, Fig. S10](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)) and verified that the transcript profile displays similar features, in particular with respect to the gain of *Hoxd13* transcripts in developing metanephros ([*SI Appendix*, Fig. S1](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental)). Mice carrying this double-mutant rescue allele displayed a normal level of water consumption ([Fig. 5*B*](#fig05){ref-type="fig"}, black arrow), as well as metanephros with a normal morphology ([Fig. 5 *C*](#fig05){ref-type="fig"}, *Right*), indicating that an ectopically expressed HOXD13 protein unable to bind DNA could revert the gain-of-function phenotype induced by the inversion. This experiment formally demonstrated that an anterior expansion of *Hoxd13* transcripts, in physiological amounts, was detrimental to the development of structures located anterior to its normal expression level, thus providing a selective pressure for the evolution and maintenance of a strong boundary effect in the *HoxD* cluster.

Discussion {#s8}
==========

Vertebrate *Hox* gene clusters display both a gene density and a level of organization thus far unmatched across metazoans, suggesting that a consolidation process occurred along with the evolution of the vertebrate lineage. This counterintuitive conclusion ([@r9]) was tentatively explained by the emergence and implementation of global and long-range regulatory controls ([@r13]), which were made possible by the 2 rounds of genome amplification that occurred at the root of vertebrates ([@r10], [@r11]). In this view, *Hox* genes became progressively more tightly organized to better respond to these remote regulations, a process that allowed the emergence of a coordinated regulation and led to functional complexity and redundancy. This transition, from a group of genes located in *cis* to a metagene, is materialized by a series of structural hallmarks such as the absence of foreign genes interspersed, the unusual scarcity of repeated elements in these gene clusters, and their reduced sizes compared with invertebrate *Hox* clusters. In this study, we challenged the functional relevance of another hallmark of these loci; that is, the fact that all HOX proteins are encoded by the same DNA strand. Of note, the only known exception thus far is the axolotl, where the *HoxA* cluster spans more than 1 Mb, mostly due to the high density of repeated elements ([@r24]). Interestingly, this neotenic animal develops at a speed globally 3 to 4 times slower than vertebrates, including other amphibians ([@r25], [@r26]).

Inversions with Various Effects. {#s9}
--------------------------------

The various inversions analyzed had different impacts on the regulation of their neighbor *Hox* genes. While the inversion of *Hoxd12* had little (if any) effect on either *Hoxd13* or *Hoxd11* regulation, the inversion of *Hoxd11* had a robust negative outcome upon *Hoxd12* transcription. In contrast, the inversion of both *Hoxd11* and *Hoxd12* in *cis* elicited a substantial gain of expression of *Hoxd13* in various developing tissues. While the functional impact of a down-regulation of *Hoxd12* has not yet been uncovered ([@r27], [@r28]), a gain of expression of *Hoxd13* in places where it is normally not expressed leads to severe conditions, due to the dominant-negative effect of the HOXD13 protein over other HOX products. In limbs and metanephros, for instance, ectopic expression of *Hoxd13* was shown to correlate with severe anomalies ([@r29], [@r30]), which in metanephros, phenocopied the combined loss of function of *Hoxa11* and *Hoxd11* ([@r31]). Therefore, the *Hoxd11--Hoxd12* inversion would very likely be detrimental to the mouse. In the current study, however, the inactivation of *Hoxd13* by a *lacZ* insertion prevented these phenotypes from developing and thus allowed for a detailed analysis to be carried out.

The transcriptional effects observed in these inversion alleles can be interpreted within 2 distinct, yet not exclusive, explanatory frameworks. The first involves the transcription dynamics of these genes; that is, the necessity due to the high density of transcription units to have all elongations occurring with the same polarity. In the wild-type situation, some transcription units do not stop before reaching the 5′ untranslated region (UTR) of the gene located in 3′. For example, some *Hoxd11* transcripts extend over *Hoxd10* and, likewise, *Hoxd4* and *Hoxd3* exons are intermingled, thus giving the possibilities for hybrid transcripts to be generated. Upon inversion, these transcription units may either collide with transcripts coming from the other DNA strand or trigger transcription of a silent gene through a promoter-cleaning effect.

The second explanatory framework involves modifications in the topology of the locus, which may directly impact upon the regulations of the various genes. For example, an inversion may either bring a promoter closer to that of the 3′-located neighbor gene, thus inducing promoter sharing and hence the misregulation of at least one of the 2 units, or bring it closer to long-range-acting enhancers. Alternatively, the inversion can reposition structural elements such as CpG islands or CTCF sites, which might in turn modify the general architecture of the locus, inducing novel enhancer--promoter contacts.

Transcriptional Interference or Topological Modification? {#s10}
---------------------------------------------------------

The decrease in the steady-state level of *Hoxd12* transcripts upon *Hoxd11* inversion may reflect a collision effect, with transcripts elongating from *Hoxd11* and reaching the *Hoxd12* 3′ UTR, thus interfering with the correct transcription of this latter gene and its mRNA's stability. In *Saccharomyces cerevisiae*, the main source of transcriptional interference is caused by the frontal collision between 2 transcriptional machineries moving on opposed DNA strands ([@r32][@r33]--[@r34]). These collisions result in mutual arrest of the 2 complexes, leading to their dissociation from the DNA through polyubiquitylation of the RNA polymerase II and the degradation of the aborted RNA transcripts ([@r35][@r36][@r37]--[@r38]). However, it is not known whether factors such as the relative elongation rates or some characteristics of the chromatin can selectively impact one RNA ([@r32], [@r39]). In the case of the *Hoxd11*--*Hoxd12* inversion, however, transcripts elongating from *Hoxd11* did not collide with those of *Hoxd13lacZ* since the latter gene was silent and covered by H3K27me3 marks. This suggested that such *Hoxd11* transcripts were able to displace these repressive chromatin marks from the *Hoxd13* promoter, thus allowing it to be transcribed in the same domains where *Hoxd11* was active.

Recent studies have highlighted the capacity of different PRC2 components to bind nascent RNA transcripts, resulting (in some cases) in the eviction of PRC2 out of the chromatin and to the modulation of its EZH2-dependent methyl-transferase activity ([@r40][@r41][@r42]--[@r43]). To demonstrate this possibility, we deleted the *Hoxd11* gene from this inverted allele so as to stop the mRNA leakage over *Hoxd13*. This was successfully achieved, as the now repositioned inverted *Hoxd12* gene sent only a few transcripts over the *Hoxd13lacZ* locus, in a much lower amount than inverted *Hoxd11* before its deletion. However, the up-regulation of *Hoxd13lacZ* in metanephros was at least as strong as in the presence of inverted *Hoxd11*, if not stronger, suggesting that such a promoter-cleaning mechanism was likely not causal.

Modifications in Local Chromatin Topology. {#s11}
------------------------------------------

Instead, the *Hoxd11*--*Hoxd12* inversion also inverted a CTCF site, which seems to be of particular importance because it is the first of a series of CTCF sites located at the 5′ extremity of the gene cluster that all display the same orientation, opposite to those sites found at more central positions within the *HoxD* locus. This very region where the polarity of CTCF sites is inverted coincides with the strongest boundary effect that separates the 2 TADs flanking the gene cluster, likely due to large loops established in either direction ([@r20]). As a consequence of the *Hoxd11--Hoxd12* inversion, this site was relocated toward a more 3′ position, with an opposite orientation. Therefore, rather than separating *Hoxd13* from the rest of the gene cluster, the new distribution of CTCF sites predicted a shift of the boundary upstream *Hoxd13* where 2 CTCF sites still have the requested orientations to induce a boundary effect.

Several observations support this "topology-based" interpretation. First, the *Hoxd13lacZ* reporter gene, which before the inversion interacted with a H3K27me3-labeled negative domain on the centromeric side of the TAD boundary (including *Evx2*), contacted the telomeric side of the boundary after the inversion. Also, in the inverted configuration, *Evx2* remained robustly covered by H3K27me3 marks, suggesting that the new TAD boundary, at least in metanephros, had been moved to between *Evx2* and *Hoxd13lacZ*. Finally, the inverted CTCF site continued to impose a boundary effect (as the CTCF site starting the series with the same orientation), yet this effect was local and did not prevent *Hoxd13lacZ* from contacting the telomeric side of the *HoxD* cluster where potential metanephros enhancers were assumed to be.

Deletion of the CTCF Site. {#s12}
--------------------------

Because of the apparent importance of this particular CTCF binding site in preventing *Hoxd13* from responding to metanephros enhancers, we deleted it from a wild-type genetic background. This deletion leads to an up-regulation of *Hoxd13* in developing metanephros, supporting the proposal that the series of CTCF sites with a telomeric orientation is necessary to block potentially deleterious contacts between *Hoxd13* and "anterior" enhancers. In fact, this specific CTCF site maps exactly at the position where an elusive "polar silencer" had been previously positioned, based on a genetic-only approach ([@r19]). The gain of expression was nevertheless transitory, likely due to the presence of other CTCF sites that make this boundary very resilient ([@r20]), and *Hoxd13* transcripts were rapidly down-regulated, which might account for the apparent absence of renal phenotype in these animals.

However, a slightly more pronounced and stable presence of *Hoxd13* mRNAs in the developing metanephros, as induced by the desequestering of the *Hoxd13* locus following a large centromeric inversion, leads to severe alterations in metanephros morphology already in heterozygous specimens. Although such a correlation between the ectopic presence of *Hoxd13* transcripts and metanephros malformation (or even agenesis) was previously observed, the causative involvement of these transcripts in triggering the abnormal phenotype was never shown. Here, we demonstrate that a mutation in the DNA-binding region of the HOXD13 protein in *cis* with the (*Nsi-Itga6*) inversion is sufficient to entirely rescue the phenotype. This result indicates that HOXD13 is indeed responsible for the observed alterations and that this dominant-negative effect is likely mediated by DNA binding.

The Logic of Global *Hox* Gene Regulation. {#s13}
------------------------------------------

These latter results demonstrate the critical importance of insulating this gene from telomeric regulatory influences and thus help us understand the general logic of the global regulation occurring at *Hox* loci. *Hox13* genes are positioned at the last position within vertebrate *Hox* clusters and as such, they are the last to be activated at most caudal positions. Due to the dominant-negative effect of their proteins over other *Hox* functions ([@r18]), their activation participates in the termination of various axial systems such as the limbs, the intestinal tract, and the major body axis, as seen by various gain- and loss-of-function approaches ([@r44][@r45]--[@r46]). Therefore, while it is essential that these genes remain associated with their respective *Hox* clusters such that they are activated in coordinated spatial and temporal manners, they must be prevented to be transcribed too early and too anteriorly, which would have dramatic effects for the developing body. We believe that this is the reason behind the evolution of such strong and resilient boundaries within *Hox* clusters, as illustrated by the unusually high concentration of CTCF sites. A similar situation was recently described for the agnathan *Hox* clusters, which seems to have been through independent genome amplifications ([@r47]). Of note, these clusters also implement temporal colinearity ([@r48]).

Along with the emergence of global enhancers located on either side on the gene cluster that progressively form these complex regulatory landscapes, these CTCF sites were used to allocate various subgroups of *Hox* genes to particular telomeric (anterior, early) enhancers ([@r49]), yet always by respecting the insulation of *Hox13* genes. This was shown for proximal limb enhancers ([@r17]), for the intestinal cecum ([@r21]), and for the developing metanephros in this work. In this view, the bimodal gene regulatory system \[proposed by Andrey et al. ([@r17]) and based on the presence of 2 TADs flanking the *HoxD* cluster\] illustrates the general logic of *Hox* gene regulation: on the one hand, a positive "morphogenetic potential" exists for the primary body axis (the ancestral structure where *Hox* genes' functions were initially deployed) to organize the body plan by regulating the rostral side of the *Hox* gene clusters; while on the other hand, a negative inhibitory function exists for those regulations located in the other side and acting upon the termination of this genetic system by activating *Hox13* genes. Such a bimodal regulatory strategy subsequently constrained and guided the evolution of regulatory innovations on either side of the cluster, along with the emergence of vertebrate morphological novelties.

Materials and Methods {#s14}
=====================

A detailed description of the mouse stocks and of chromatin immunoprecipitation sequencing (ChIP-seq), ChIPmentation, 4C-seq, qRT-PCR, RNA-seq, WISH, X-gal staining, histology, water consumption, and the genomic data can be found in [*SI Appendix*, *Material and Methods*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1904602116/-/DCSupplemental).

Animal Experimentation. {#s15}
-----------------------

All experiments were performed in agreement with the Swiss law on animal protection, under license no. GE 81/14 (to D.D.). The use of animals in these experiments was approved by the "Commission Consultative de l'Expérimentation Animale du Canton de Genève."

Accession Nos. {#s16}
--------------

RNA-seq, 4C-seq, ChIP-seq, and ChIPmentation datasets are available from the National Center for Biotechnology Information Gene Expression Omnibus database under accession no. GSE127870.
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